Healthpeak Properties (DOC) to Release Earnings on Monday

Healthpeak Properties (NYSE:DOC) will likely be issuing its Q4 2025 results after the market closes on Monday, February 2nd. Analysts expect the company to announce earnings of $0.45 per share and revenue of $685.1350 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Tuesday, February 3, 2026 at 10:00 AM ET.

Healthpeak Properties Price Performance

Shares of DOC opened at $17.22 on Friday. Healthpeak Properties has a fifty-two week low of $15.71 and a fifty-two week high of $21.28. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.11. The company has a market cap of $11.97 billion, a P/E ratio of -344.33, a PEG ratio of 4.32 and a beta of 1.12. The firm’s 50 day moving average price is $17.00 and its 200 day moving average price is $17.65.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.1017 dividend. The ex-dividend date is Tuesday, March 17th. This represents a c) dividend on an annualized basis and a dividend yield of 7.1%. Healthpeak Properties’s dividend payout ratio is currently -2,440.00%.

Analysts Set New Price Targets

Several equities analysts have weighed in on DOC shares. Robert W. Baird dropped their target price on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a report on Wednesday, November 12th. Cantor Fitzgerald set a $17.00 price objective on Healthpeak Properties in a report on Monday, January 5th. Wells Fargo & Company lifted their target price on Healthpeak Properties from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. The Goldman Sachs Group began coverage on Healthpeak Properties in a research note on Friday, January 9th. They set a “neutral” rating and a $17.00 price target for the company. Finally, Jefferies Financial Group downgraded Healthpeak Properties from a “buy” rating to a “hold” rating and cut their price objective for the stock from $21.00 to $17.00 in a report on Monday, December 15th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Healthpeak Properties currently has an average rating of “Hold” and an average target price of $19.67.

Institutional Investors Weigh In On Healthpeak Properties

A number of large investors have recently modified their holdings of DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock worth $153,520,000 after acquiring an additional 7,007,777 shares in the last quarter. Bank of America Corp DE raised its stake in shares of Healthpeak Properties by 28.5% during the third quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock valued at $190,292,000 after purchasing an additional 2,206,222 shares during the period. State Street Corp raised its stake in shares of Healthpeak Properties by 1.8% during the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock valued at $947,889,000 after purchasing an additional 895,460 shares during the period. Verition Fund Management LLC lifted its position in shares of Healthpeak Properties by 242.2% during the third quarter. Verition Fund Management LLC now owns 1,195,452 shares of the real estate investment trust’s stock worth $22,893,000 after purchasing an additional 846,066 shares in the last quarter. Finally, UBS Group AG boosted its stake in shares of Healthpeak Properties by 33.6% in the third quarter. UBS Group AG now owns 3,349,298 shares of the real estate investment trust’s stock valued at $64,139,000 after purchasing an additional 841,614 shares during the period. Institutional investors and hedge funds own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.